Centene Finds Profit Growth Even as Medicaid Membership Softens
Centene beat Q2 earnings and revenue estimates, raised its 2026 outlook, improved medical cost trends, and reported lower Medicaid membership.
Read original at benzingaStocks · News reference
Barclays Maintains Underweight on Molina Healthcare, Lowers Price Target to $180
Barclays analyst Andrew Mok maintains Molina Healthcare (NYSE:MOH) with a Underweight and lowers the price target from $184 to $180.
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Jul 24, 2026, 2:19 PM
- Checked
- Jul 24, 2026, 2:19 PM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
MOH stock has given up its prior loss. Molina Healthcare shares were trading lower after Wells Fargo lowered its price target on the stock from $235 to $220.
Read original at benzingaMolina Healthcare shares are trading lower after Wells Fargo lowered its price target on the stock from $235 to $220.
Read original at benzingaWells Fargo Maintains Equal-Weight on Molina Healthcare, Lowers Price Target to $220
Wells Fargo analyst Stephen Baxter maintains Molina Healthcare (NYSE:MOH) with a Equal-Weight and lowers the price target from $235 to $220.
Read original at benzinga